Long elimination half-life of idraparinux may explain major bleeding and recurrent events of patients from the van Gogh trials - Harenberg,J.; Vukojevic,Y.; Mikus,G.; Joerg,I.; Weiss,C. (J Thromb Haemost, 2008)